FDA Drug Application (022522) for DALIRESP by ASTRAZENECA PHARMS

Back to FDA Applications sponsored by ASTRAZENECA PHARMS

Application Number022522
Product Number001
FormTABLET;ORAL
Dosage500MCG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDALIRESP
Active IngredientROFLUMILAST

Active IngredientCount
List of drugs with Active Ingredient ROFLUMILAST2


Back to FDA Applications sponsored by ASTRAZENECA PHARMS